Status:

COMPLETED

Hypersensitivity in Tourette Syndrome

Lead Sponsor:

National Institute of Neurological Disorders and Stroke (NINDS)

Conditions:

Tourette's Syndrome

Eligibility:

All Genders

18-65 years

Brief Summary

This study will investigate how the sensitivity to touch and smell in patients with Tourette syndrome (TS) may differ from that of people without TS. TS is a neurological disorder that causes people t...

Detailed Description

OBJECTIVE: This study will explore sensory phenomena associated with Tourette syndrome (TS). The first part will evaluate threshold levels versus perceived intensity of tactile and olfactory stimuli ...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • Healthy Volunteers ages 18 to 65 who have who have given their consent.
  • Patients will be ages 18 to 65 and have clinically documented Tourette's syndrome or chronic motor tic disorder as defined by DSM-IV-TR (American Psychiatric Association, 2000) and evaluation of tic severity using the Yale Tic Scale (YGTS). This criterion will be established by preliminary screening in the NINDS Movement Disorders Outpatient Clinic. Structure Clinical Interview for (DSMIV SCID) will be administered to all patients to ensure that strict DSM-IV criteria for Tourette Syndrome have been met and to assess for possible comorbid psychiatric disorders.
  • Patients with at least moderate premonitory urge, as evaluated with the PUTS.
  • EXCLUSION CRITERIA:
  • Subjects younger than 18 or older than 65 years.
  • Subjects with 1) major depression, 2) bipolar disorder, or 3) psychotic disorder.
  • Subjects who are unable to abstain from alcohol or any psychiatric medications 24 hours prior to the study.
  • Subjects with acute or chronic upper respiratory illness, nasal allergies, or subjects using medications to treat these conditions, including antihistamines, nasal topical steroids, vasoconstrictor nasal sprays, or normal saline sprays.
  • Women who are pregnant.
  • Individuals with Restless Legs syndrome.
  • Individuals with a diagnosis of peripheral neuropathy.

Exclusion

    Key Trial Info

    Start Date :

    August 21 2006

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    May 24 2011

    Estimated Enrollment :

    46 Patients enrolled

    Trial Details

    Trial ID

    NCT00368433

    Start Date

    August 21 2006

    End Date

    May 24 2011

    Last Update

    July 2 2017

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institutes of Health Clinical Center, 9000 Rockville Pike

    Bethesda, Maryland, United States, 20892